Alternatively, it may be possible that artificial depletion of pDCs in experimental animal models potentiated the anti-cancer immune response through the activation of other damaged DNA-sensing pathways, i.e. AIM2 or cGAS-STING pathways, with DNA remaining in the TME. The gene discussed is AIM2; the disease is cancer.